title: [Coagulative activity of the amniotic fluid].
abstract: An ultracentrifugation study has shown thromboplastin to be the only blood coagulating agent, present in the amniotic fluid (AF). Its AF level shows no correlation to the rate of intrapartum or early postpartum thrombohemorrhagic complications, which may rather be related to the AF volume penetrating into the bloodstream. AF thromboplastin has also been shown to have an antiheparin activity.
authors.forename: O A
authors.initials: OA
authors.lastname: Tersenov
authors.forename: I V
authors.initials: IV
authors.lastname: Mikhaleva
authors.forename: V A
authors.initials: VA
authors.lastname: Usol'tseva
authors.forename: A Sh
authors.initials: ASh
authors.lastname: Byshevskiĭ
mesh_terms: D000653:Amniotic Fluid / Q000032:analysis / Q000502:physiology*; D000818:Animals; D005260:Female; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D051381:Rats; D013925:Thromboplastin / Q000008:administration & dosage / Q000032:analysis* / Q000493:pharmacokinetics; D013997:Time Factors; D014461:Ultracentrifugation
chemical_list: D013925:Thromboplastin
vernacular_title: O svertyvaiushcheĭ aktivnosti okoloplodnykh vod.